Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-04-20 @ 1:46 PM
Study NCT ID:
NCT04948034
Status:
UNKNOWN
Last Update Posted:
2021-08-27
First Post:
2021-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)
Sponsor:
Fudan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FDRT-2020-274-2194
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None